Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Illumina Inc (NASDAQ:ILMN)

170.42
Delayed Data
As of 4:00pm ET
 -1.79 / -1.04%
Today’s Change
127.10
Today|||52-Week Range
213.27
-11.21%
Year-to-Date
Thermo Fisher to Buy Illumina? Not So Fast
8:45am / MotleyFool.com - Paid Partner Content
3 Top Stocks You Can Buy and Hold for the Next Decade
Aug 23 / MotleyFool.com - Paid Partner Content
Illumina Keen on Genome Network Growth & Global Expansion
Aug 26 / Zacks.com - Paid Partner Content
Illumina Rallies on Rumors of Takeover by Thermo Fisher
Aug 23 / Zacks.com - Paid Partner Content
Stock Market News for August 25, 2016
Aug 25 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close172.21
Today’s open172.11
Day’s range170.25 - 172.83
Volume582,876
Average volume (3 months)1,260,891
Market cap$25.2B
Dividend yield--
Data as of 4:00pm ET, 08/29/2016

Growth & Valuation

Earnings growth (last year)+30.80%
Earnings growth (this year)+6.33%
Earnings growth (next 5 years)+13.50%
Revenue growth (last year)+19.25%
P/E ratio58.4
Price/Sales12.89
Price/Book13.66

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...-0.23-0.46%
TECHBio-Techne Corp+0.35+0.33%
JUNOJuno Therapeutics In...-0.45-1.39%
XONIntrexon Corp-0.65-2.49%
Data as of 4:01pm ET, 08/29/2016

Financials

Next reporting dateOctober 18, 2016
EPS forecast (this quarter)$0.91
Annual revenue (last year)$2.2B
Annual profit (last year)$461.6M
Net profit margin20.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Francis A. deSouza
Senior Vice President-Global Quality &
Operations
Robert P. Ragusa
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs